Citas bibligráficas
Castro, F., (2022). Evaluación del potencial efecto neuroprotector de macamidas sintéticas en la reducción de daño cerebral, conservación de la respuesta sensorio - motora y alivio del deterioro de memoria y aprendizaje espacial causados por isquemia cerebral focal en ratas, Cusco – 2021. [Universidad Andina del Cusco]. https://hdl.handle.net/20.500.12557/5098
Castro, F., Evaluación del potencial efecto neuroprotector de macamidas sintéticas en la reducción de daño cerebral, conservación de la respuesta sensorio - motora y alivio del deterioro de memoria y aprendizaje espacial causados por isquemia cerebral focal en ratas, Cusco – 2021. []. PE: Universidad Andina del Cusco; 2022. https://hdl.handle.net/20.500.12557/5098
@misc{renati/954989,
title = "Evaluación del potencial efecto neuroprotector de macamidas sintéticas en la reducción de daño cerebral, conservación de la respuesta sensorio - motora y alivio del deterioro de memoria y aprendizaje espacial causados por isquemia cerebral focal en ratas, Cusco – 2021.",
author = "Castro García, Flavia Alejandra",
publisher = "Universidad Andina del Cusco",
year = "2022"
}
Strokes are one of the leading causes of death and disability worldwide. Previous studies have shown the neuroprotective effect of Lepidium meyenii pentane extract (maca) as well as its separate macamides. The present study aims to ascertain the protective effect of a synthetic macamide N-benzyloctadecanamide (MCH1) on morphological conservation, sensory-motor and disturbs on spatial learning and memory. To this end, the middle cerebral artery occlusion (MCAO) model was produced to induce focal cerebral ischemia in Sprague Dawley rats. An intraperitoneal dose of 3 mg/kg of MCH1 was administered prior to occlusion; this dose is repeated every 24 hours for 10 days. A battery of neurological assessments was applied on day 3 and day 10 after stroke, and cognitive assessments were performed pre- and post-stroke. The results show treatment with MCH1 reduces significantly the infarct area at day 10 post stroke, specifically in sensory and motor cortex. MCH1 treatment also reduce sensory-motor deficit in stroke rats. MCAO animals haven´t showed any change in cognitive function. These results suggest a potential neuroprotective effect of macamide MCH1 against focal ischemic damage, reducing the injury process and limiting the infarct area, as well as the preserved the sensory-motor function.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons